Introduction

Welcome to the website of the project  PEDDOSE.NET:
Dosimetry and Health Effects of Diagnostic Applications of Radiopharmaceuticals with particular emphasis on the use in children and adolescents.

Nuclear medicine contributes significantly to the health, healthcare and quality of life of European citizens, particularly in major clinical areas such as cancer and cardiovascular disease. Every year, over 6 million patients benefit from a nuclear medicine procedure in Europe, 95% of which are diagnostic and 5% therapeutic. The evaluation of the impact on patients' health of small and non-repetitive or less repetitive doses of radioactive substances, as currently used in diagnostic imaging procedures, has up to now not been addressed systematically in a European context. This is where the project Peddose.net steps in.

This Support Action started in April 2010 and is partially funded by the European Commission under the FP 7 call: HEALTH-2009-1.2-6: Evaluation of the potential health impact of diagnostic imaging agents doses.